259 related articles for article (PubMed ID: 19204654)
1. Early symptom change prediction of remission in depression treatment.
Katz MM; Meyers AL; Prakash A; Gaynor PJ; Houston JP
Psychopharmacol Bull; 2009; 42(1):94-107. PubMed ID: 19204654
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
Khan A; Bose A; Alexopoulos GS; Gommoll C; Li D; Gandhi C
Clin Drug Investig; 2007; 27(7):481-92. PubMed ID: 17563128
[TBL] [Abstract][Full Text] [Related]
5. Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
Mallinckrodt CH; Prakash A; Houston JP; Swindle R; Detke MJ; Fava M
Neuropsychobiology; 2007; 56(2-3):73-85. PubMed ID: 18037817
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials.
Lam RW; Andersen HF; Wade AG
Int Clin Psychopharmacol; 2008 Jul; 23(4):181-7. PubMed ID: 18545055
[TBL] [Abstract][Full Text] [Related]
7. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Lam RW; Lönn SL; Despiégel N
Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
[TBL] [Abstract][Full Text] [Related]
8. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
[TBL] [Abstract][Full Text] [Related]
9. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder.
Brecht S; Kajdasz D; Ball S; Thase ME
Int Clin Psychopharmacol; 2008 Nov; 23(6):317-24. PubMed ID: 18854719
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.
Kornstein SG; Wohlreich MM; Mallinckrodt CH; Watkin JG; Stewart DE
J Clin Psychiatry; 2006 May; 67(5):761-70. PubMed ID: 16841626
[TBL] [Abstract][Full Text] [Related]
12. An open, non-randomised comparison of escitalopram and duloxetine for the treatment of subjects with Generalized Anxiety Disorder.
Pierò A; Locati E
Hum Psychopharmacol; 2011 Jan; 26(1):63-71. PubMed ID: 21305612
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
14. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
Clayton A; Kornstein S; Prakash A; Mallinckrodt C; Wohlreich M
J Sex Med; 2007 Jul; 4(4 Pt 1):917-29. PubMed ID: 17627739
[TBL] [Abstract][Full Text] [Related]
15. Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.
Bose A; Tsai J; Li D
Clin Drug Investig; 2012 Jun; 32(6):373-85. PubMed ID: 22559255
[TBL] [Abstract][Full Text] [Related]
16. Baseline severity of depression predicts antidepressant drug response relative to escitalopram.
Kilts CD; Wade AG; Andersen HF; Schlaepfer TE
Expert Opin Pharmacother; 2009 Apr; 10(6):927-36. PubMed ID: 19317630
[TBL] [Abstract][Full Text] [Related]
17. Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram.
Raskin J; George T; Granger RE; Hussain N; Zhao GW; Marangell LB
J Psychiatr Res; 2012 May; 46(5):667-74. PubMed ID: 22410206
[TBL] [Abstract][Full Text] [Related]
18. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
[TBL] [Abstract][Full Text] [Related]
19. Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors.
Sheehan DV; Mancini M; Wang J; Berggren L; Cao H; Dueñas HJ; Yue L
Hum Psychopharmacol; 2016 Jan; 31(1):53-63. PubMed ID: 26331440
[TBL] [Abstract][Full Text] [Related]
20. Attributes of response in depressed patients switched to treatment with duloxetine.
Sagman D; McIntosh D; Lee MS; Li H; Ruschel S; Hussain N; Granger RE; Lee AC; Raskin J
Int J Clin Pract; 2011 Jan; 65(1):73-81. PubMed ID: 21078010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]